Related references
Note: Only part of the references are listed.Recognition of Human IgG1 by Fcγ Receptors: Structural Insights from Hydrogen-Deuterium Exchange and Fast Photochemical Oxidation of Proteins Coupled with Mass Spectrometry
Liuqing Shi et al.
BIOCHEMISTRY (2019)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
A single amino acid distorts the Fc receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a
Jacob T. Roberts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development
Danlin Yang et al.
MABS (2017)
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa
Yoshitake Sakae et al.
SCIENTIFIC REPORTS (2017)
Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma
Akihiro Fujikawa et al.
SCIENTIFIC REPORTS (2016)
Fc gamma receptors: glycobiology and therapeutic prospects
Jerrard M. Hayes et al.
JOURNAL OF INFLAMMATION RESEARCH (2016)
Structural analysis of Fc/FcR complexes: a blueprint for antibody design
Jose M. M. Caaveiro et al.
IMMUNOLOGICAL REVIEWS (2015)
Structural Basis for Dimer Formation of Human Condensin Structural Maintenance of Chromosome Proteins and Its Implications for Single-stranded DNA Recognition
Susumu Uchiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Rapid evaluation of N-glycosylation status of antibodies with chemiluminescent lectin-binding assay
Masayoshi Onitsuka et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2015)
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors
Yuya Isoda et al.
PLOS ONE (2015)
Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant
Futa Mimoto et al.
MABS (2013)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
The interactions of therapeutic antibodies with Fc receptors
Marcello Albanesi et al.
IMMUNOLOGY LETTERS (2012)
Guide to video recording of structure dynamics and dynamic processes of proteins by high-speed atomic force microscopy
Takayuki Uchihashi et al.
NATURE PROTOCOLS (2012)
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Tsunehiro Mizushima et al.
GENES TO CELLS (2011)
The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability Studies
Damian Houde et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
Damian Houde et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation
Mami Shibata-Koyama et al.
GLYCOBIOLOGY (2009)
Production of therapeutic antibodies with controlled fucosylation
Naoko Yamane-Ohnuki et al.
MABS (2009)
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
John O. Richards et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The carbohydrate at FcγRIIIa Asn-162 -: an element required for high affinity binding to non-fucosylated IgG glycoforms
C Ferrara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma
R Niwa et al.
CANCER RESEARCH (2004)
Measurement of soluble Fcγ receptor type IIIa derived from macrophages in plasma:: increase in patients with rheumatoid arthritis
M Masuda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Evidence of allosteric conformational changes in the antibody constant region upon antigen binding
M Oda et al.
INTERNATIONAL IMMUNOLOGY (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design
EO Saphire et al.
SCIENCE (2001)
The structure of a human type III Fcγ receptor in complex with Fc
S Radaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
Crystal structure of the exctracellular domain of a human Fc gamma RIII
YH Zhang et al.
IMMUNITY (2000)
Share Paper
